Please use a PC Browser to access Register-Tadawul
Get It
TuHURA Biosciences shares are trading lower. The company announced it filed an IND with the FDA Division of Hematologic Malignancies 1 for the study of TBS-2025 in blood-related cancer treatment.
TuHURA Biosciences, Inc. HURA | 2.00 2.07 | +11.11% +3.50% Pre |
